期刊文献+

应用组织芯片技术研究Skp2、p27~kip1在肾细胞癌中的表达及意义 被引量:2

Detection of Skp2 and p27^(kip1) expression in human renal cell carcinoma using tissue chip technique
下载PDF
导出
摘要 目的检测S期激酶相关蛋白2(Skp2)和抑癌基因p27kip1在肾细胞癌(RCC)中的表达,探讨其与肾细胞癌生物学特征的关系及意义。方法采用组织芯片技术及免疫组化SP法检测Skp2和p27kip1在80例肾细胞癌组织和40例癌旁正常肾组织中的表达,并做统计学分析。结果(1)Skp2在肾细胞癌中的表达率高于正常肾组织(P=0.025);随肿瘤恶性程度增加,Skp2阳性表达率升高(P=0.002),其表达率与肾癌患者的年龄、性别、临床分期、淋巴结转移及肿瘤大小无关(P>0.05)。(2)p27kip1在肾细胞癌中的表达率低于正常肾组织(P=0.007);p27kip1阳性表达率与肿瘤分级及临床分期呈负相关((P<0.05),与肾癌患者的年龄、性别、淋巴结转移及肿瘤大小无关(P>0.05)。(3)Skp2与p27kip1表达呈显著负相关(r=-0.273,P=0.014)。结论肾细胞癌中Skp2蛋白的过度表达与p27kip1蛋白降解增强有关,提示Skp2可能在肾细胞癌发生中扮演着重要角色。 Objective To detect the expression of skp2 and p27 kipl in human renal cell carcinoma (RCC) using tissue chip technique, and evaluate the relationship between the proteins and the biological behavior of RCC. Methods Tissue chip technique and. immunohistochemical SP method was used to detect the expression of skp2 and p27^kipl in normal and tumor tissues. Results The positivity rate of Skp2 in RCC was significantly higher than that in normal renal tissues (P=0.025). The positivity rate of Skp2 expression in RCC was significantly correlated to poor differentiation of the tumor (P=-0.002), and was not associated with the patients gender, age, tumor size, lymph node metastasis and stages of RCC (P〉0.05). The positivity rate of p27^kipl in RCC was significantly lower than that in normal renal tissues (P=-0.007). The positivity rate of p27^kipl expression was inversely correlated to the malignancy and stage of RCC (P〈0.05), but not with the patients' age, gender, lymph node metastasis and tumor size (/9〉0.05). An inverse correlation was noted between Skp2 and p27^kipl expressions (r= -0.273, P=-0.014). Conclusion Overexpression of Skp2 protein may lead to decreased p27^kipl level in RCC, indicating its involvement in the carcinogenesis and development of RCC.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2008年第4期642-645,共4页 Journal of Southern Medical University
关键词 肾肿瘤 组织芯片 S期激酶相关蛋白2 抑癌基因P27 kidney neoplasms tissue chip Skp2 p27
  • 相关文献

参考文献9

  • 1Walsh P, Reitik A, Vaughan D, et al. Camobell's Urology[M]. 7th ed. Harcourt Publishers Limited, 1998: 2360-4.
  • 2许丽彦,黄峰岐,张晓强,穆英杰.P^(27)在肾细胞癌中的表达研究[J].黑龙江医学,2006,30(7):492-493. 被引量:2
  • 3Langner C, von Wasielewski R, Ratschek M, et al. Biological significance of p27 and Skp2 expressionin renal cell carcinoma [J]. Virchows Arch, 2004, 445(6): 631-6.
  • 4Langner C, von Wasielewski R, Ratschek M, et al. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma[J]. Urology, 2004, 64(3): 611-6.
  • 5邵志滨,谢海龙.组织芯片技术及其在胃癌研究中的应用[J].国际病理科学与临床杂志,2007,27(3):235-238. 被引量:5
  • 6Polyak K, Kato JY, Solomon MJ, et al. p27^Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest[J]. Genes Dev, 1994, 8(1): 9-22.
  • 7Nitti D, Bclluco C, Mammano E, et al. Low level of p27 (kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome [J]. J Surg Oncol, 2002, 81 (4): 167-75.
  • 8Bomstein G, Bloom J, Sitry-Shevah D, et al. Role of the SCFSkp2 ubiquitin ligase in the degradation ofp21Cipl in S phase[J]. J Biol Chem, 2003, 278(28): 25752-7.
  • 9Sui L, Dong Y, Watanabe Y, et al. Clinical significance of Skp2 expression, alone and combined with Jabl and p27 in epithelial ovarian tumors[J]. Oncol Rep, 2006, 15(4): 765-71.

二级参考文献30

  • 1师建国,王丽,张勇,闫庆国.抗凋亡蛋白BAG-1在胃癌组织芯片中的表达及意义[J].细胞与分子免疫学杂志,2004,20(4):498-499. 被引量:5
  • 2温黎,付静,李新功,徐志秀,吴起嵩.应用组织芯片技术对胃癌组织中cyclinE和p21^(WAF1)蛋白表达观察的体会[J].实用医技杂志,2004,11(07A):1162-1164. 被引量:2
  • 3王青,吕宁,窦科峰,薛丽艳,钱海利,房青,谢永强,刘秀云,杨建国,马庆久,鲁建国,詹启敏,林晨.利用组织芯片技术检测硒蛋白P在胃癌组织中的表达[J].肿瘤防治杂志,2005,12(10):721-724. 被引量:3
  • 4Walsh P,Reitik A,Vaughan D,et al.Camobell's Urology,7th Edition Harcourt Publishers Limited,1998,2 360~2 364.
  • 5Motokura T,Bloom T,Kim H G,et al.A nove cyclin encoded by a bcl-linked candidate oncogene[J].Natrue,1991,350,512~515.
  • 6Smitherman M,Lee K,Swanger J,et al.Characterization and targeted disruption of murine Nup50,a P27 (kipl)-interacting component of the nuelear pore complex[J].Mol-cell-Biol,2000,20(15):5 631~42.
  • 7Muraka R S,Lenferink A E,Simpson J,et al.Cyclin-dependent kinase inhibitor P27(kipl) is required for mouse mammary gland morphogenesis and function[J].J-Cell-Biol,2001,153(5):917~32.
  • 8Katayose Y,Kim M,Rakker ANS,et al.Promoting apoptosis:A novel activity associated with the cyclin-dependent kinase inhibitor P27[J].Cancer Res,1997,57(24):5 441~5 445.
  • 9Pagano M,Tam S W,Theodoras A M,et al.Role of the ubiquitin pathway in regulating abundance of the cyclin-dependent kinase inhibitor[J].Science,1995,269(5 224):682~685.
  • 10Motokura T,Keyomarsi K,Kronenberg H M,et al.Cloning and characterization of human cyclin D3,a cDNA closely related in sequence to the PRAD/cyclinD1 protoncogene[J].Biol Chem,1992,267:20 412~20 415.

共引文献5

同被引文献11

  • 1Langner C, Von WR, Ratschek M, et al. Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic turnout tissues using a tissue microarray technique [ J ]. Virchows Arch, 2004, 445(6): 631-6.
  • 2Polyak K, Kato JY, Solomon MJ, et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest[J]. Genes Dev, 1994, 8(1): 9-22.
  • 3Pertia A, Nikoleishvili D, Trsintsadze O, et al. Loss of p27(Kip1) CDKI is a predictor of poor recurrence-free and cancer-specific survival in patients with renal cancer[J]. Int Urol Nephrol, 2007, 39 (2): 381-7.
  • 4Kim J, Jonasch E, Alexander A, et al. Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma [J]. Clin Cancer Res, 2009, 15(1): 81-90.
  • 5Pertia A, Nikoleishvili D, Trsintsadze O, et al. Immunoreaetivity of p27 (Kip1), cyclin D3, and Ki67 in conventional renal cell carcinoma [ J ]. Int Urol Nephrol, 2009, 41 (2): 243-9.
  • 6Migita T, Oda Y, Masuda K, et al. Inverse relationship between E-cadherin and p27Kip1 expression in renal cell carcinoma[J]. Int J Oncol, 2008, 33(1): 41-7.
  • 7Hedberg Y, Ljungberg B, Roos G, et al. Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray[J ]. Br J Cancer, 2003, 88(9): 1417-23.
  • 8Migita T, Oda Y, Naito S, et al. Low expression of p27 (Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma[J]. Cancer, 2002, 94(4): 973-9.
  • 9Kawamata N, Morosetti R, Miller CW, et al. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies[J]. Cancer Res, 1995, 55(11): 2266-9.
  • 10Hui AM, Sun L, Kanai Y, et al. Reduced p27Kip1 expression in hepatocellular carcinomas[J]. Cancer Lett, 1998, 132(1-2): 67-73.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部